Allergan (AGN) Call for Special Meeting by Pershing Square

First Page		Document Content
Date: 2014-09-16 18:31:09 Corporations law Financial economics Management Equity securities Business law Shareholder rights plan Allergan Valeant Pharmaceuticals Corporate governance Business Stock market Finance		Allergan (AGN) Call for Special Meeting by Pershing Square Add to Reading List Source URL: blogs.reuters.com Download Document from Source Website File Size: 385,68 KB Share Document on Facebook

	Valeant Pharmaceuticals International, Inc. 400 Somerset Corporate Boulevard, Bridgewater, NJ 08807 DocID: 1rD6j - View Document
	March 4, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: DocID: 1rdax - View Document
	February 5, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: DocID: 1r6rO - View Document
	Investor Presentation Jan 31, 2016 TM TSX-V: SBM DocID: 1r4gv - View Document
	Sequoia Fund, Inc. ANNUAL REPORT DECEMBER 31, 2013 DocID: 1qfcU - View Document